199 related articles for article (PubMed ID: 35022313)
21. ARID1A-dependent maintenance of H3.3 is required for repressive CHD4-ZMYND8 chromatin interactions at super-enhancers.
Reske JJ; Wilson MR; Armistead B; Harkins S; Perez C; Hrit J; Adams M; Rothbart SB; Missmer SA; Fazleabas AT; Chandler RL
BMC Biol; 2022 Sep; 20(1):209. PubMed ID: 36153585
[TBL] [Abstract][Full Text] [Related]
22. STON2 negatively modulates stem-like properties in ovarian cancer cells via DNMT1/MUC1 pathway.
Xu S; Yue Y; Zhang S; Zhou C; Cheng X; Xie X; Wang X; Lu W
J Exp Clin Cancer Res; 2018 Dec; 37(1):305. PubMed ID: 30518424
[TBL] [Abstract][Full Text] [Related]
23. MUC1-C integrates activation of the IFN-γ pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer.
Yamashita N; Long M; Fushimi A; Yamamoto M; Hata T; Hagiwara M; Bhattacharya A; Hu Q; Wong KK; Liu S; Kufe D
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33495298
[TBL] [Abstract][Full Text] [Related]
24. MUC1-C oncoprotein activates ERK→C/EBPβ signaling and induction of aldehyde dehydrogenase 1A1 in breast cancer cells.
Alam M; Ahmad R; Rajabi H; Kharbanda A; Kufe D
J Biol Chem; 2013 Oct; 288(43):30892-903. PubMed ID: 24043631
[TBL] [Abstract][Full Text] [Related]
25. ARID1A-dependent permissive chromatin accessibility licenses estrogen-receptor signaling to regulate circadian rhythms genes in endometrial cancer.
Hu H; Chen Z; Ji L; Wang Y; Yang M; Lai R; Zhong Y; Zhang X; Wang L
Cancer Lett; 2020 Nov; 492():162-173. PubMed ID: 32858102
[TBL] [Abstract][Full Text] [Related]
26. ARID1A facilitates KRAS signaling-regulated enhancer activity in an AP1-dependent manner in colorectal cancer cells.
Sen M; Wang X; Hamdan FH; Rapp J; Eggert J; Kosinsky RL; Wegwitz F; Kutschat AP; Younesi FS; Gaedcke J; Grade M; Hessmann E; Papantonis A; Strӧbel P; Johnsen SA
Clin Epigenetics; 2019 Jun; 11(1):92. PubMed ID: 31217031
[TBL] [Abstract][Full Text] [Related]
27. The reactive tumor microenvironment: MUC1 signaling directly reprograms transcription of CTGF.
Behrens ME; Grandgenett PM; Bailey JM; Singh PK; Yi CH; Yu F; Hollingsworth MA
Oncogene; 2010 Oct; 29(42):5667-77. PubMed ID: 20697347
[TBL] [Abstract][Full Text] [Related]
28. mTORC1 Promotes ARID1A Degradation and Oncogenic Chromatin Remodeling in Hepatocellular Carcinoma.
Zhang S; Zhou YF; Cao J; Burley SK; Wang HY; Zheng XFS
Cancer Res; 2021 Nov; 81(22):5652-5665. PubMed ID: 34429326
[TBL] [Abstract][Full Text] [Related]
29. Identification of chromatin accessibility domains in human breast cancer stem cells.
Hardy K; Wu F; Tu W; Zafar A; Boulding T; McCuaig R; Sutton CR; Theodoratos A; Rao S
Nucleus; 2016; 7(1):50-67. PubMed ID: 26962893
[TBL] [Abstract][Full Text] [Related]
30. SMARCB1 is required for widespread BAF complex-mediated activation of enhancers and bivalent promoters.
Nakayama RT; Pulice JL; Valencia AM; McBride MJ; McKenzie ZM; Gillespie MA; Ku WL; Teng M; Cui K; Williams RT; Cassel SH; Qing H; Widmer CJ; Demetri GD; Irizarry RA; Zhao K; Ranish JA; Kadoch C
Nat Genet; 2017 Nov; 49(11):1613-1623. PubMed ID: 28945250
[TBL] [Abstract][Full Text] [Related]
31. Acute depletion of the ARID1A subunit of SWI/SNF complexes reveals distinct pathways for activation and repression of transcription.
Blümli S; Wiechens N; Wu MY; Singh V; Gierlinski M; Schweikert G; Gilbert N; Naughton C; Sundaramoorthy R; Varghese J; Gourlay R; Soares R; Clark D; Owen-Hughes T
Cell Rep; 2021 Nov; 37(5):109943. PubMed ID: 34731603
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of Arid1a increases stem/progenitor cell-like properties of liver cancer.
Wang L; Deng CH; Luo Q; Su XB; Shang XY; Song SJ; Cheng S; Qu YL; Zou X; Shi Y; Wang Q; Du SC; Han ZG
Cancer Lett; 2022 Oct; 546():215869. PubMed ID: 35964817
[TBL] [Abstract][Full Text] [Related]
33. The transcription factor GLI1 cooperates with the chromatin remodeler SMARCA2 to regulate chromatin accessibility at distal DNA regulatory elements.
Safgren SL; Olson RLO; Vrabel AM; Almada LL; Marks DL; Hernandez-Alvarado N; Gaspar-Maia A; Fernandez-Zapico ME
J Biol Chem; 2020 Jun; 295(26):8725-8735. PubMed ID: 32376693
[TBL] [Abstract][Full Text] [Related]
34. MUC1-C integrates aerobic glycolysis with suppression of oxidative phosphorylation in triple-negative breast cancer stem cells.
Yamashita N; Withers H; Morimoto Y; Bhattacharya A; Haratake N; Daimon T; Fushimi A; Nakashoji A; Thorner AR; Isenhart E; Rosario S; Long MD; Kufe D
iScience; 2023 Nov; 26(11):108168. PubMed ID: 37915591
[TBL] [Abstract][Full Text] [Related]
35. Oncogenic Notch Promotes Long-Range Regulatory Interactions within Hyperconnected 3D Cliques.
Petrovic J; Zhou Y; Fasolino M; Goldman N; Schwartz GW; Mumbach MR; Nguyen SC; Rome KS; Sela Y; Zapataro Z; Blacklow SC; Kruhlak MJ; Shi J; Aster JC; Joyce EF; Little SC; Vahedi G; Pear WS; Faryabi RB
Mol Cell; 2019 Mar; 73(6):1174-1190.e12. PubMed ID: 30745086
[TBL] [Abstract][Full Text] [Related]
36. MUC1-C regulates NEAT1 lncRNA expression and paraspeckle formation in cancer progression.
Bhattacharya A; Wang K; Penailillo J; Chan CN; Fushimi A; Yamashita N; Daimon T; Haratake N; Ozawa H; Nakashoji A; Shigeta K; Morimoto Y; Miyo M; Kufe DW
Oncogene; 2024 May; ():. PubMed ID: 38802648
[TBL] [Abstract][Full Text] [Related]
37. EBF2 transcriptionally regulates brown adipogenesis via the histone reader DPF3 and the BAF chromatin remodeling complex.
Shapira SN; Lim HW; Rajakumari S; Sakers AP; Ishibashi J; Harms MJ; Won KJ; Seale P
Genes Dev; 2017 Apr; 31(7):660-673. PubMed ID: 28428261
[TBL] [Abstract][Full Text] [Related]
38. MiR-140-5p inhibits cell proliferation and metastasis by regulating MUC1 via BCL2A1/MAPK pathway in triple negative breast cancer.
Yu B; You W; Chen G; Yu Y; Yang Q
Cell Cycle; 2019 Oct; 18(20):2641-2650. PubMed ID: 31411515
[TBL] [Abstract][Full Text] [Related]
39. Identification of FRA-1 as a novel player in pancreatic cancer in cooperation with a MUC1: ERK signaling axis.
Hanson RL; Brown RB; Steele MM; Grandgenett PM; Grunkemeyer JA; Hollingsworth MA
Oncotarget; 2016 Jun; 7(26):39996-40011. PubMed ID: 27220889
[TBL] [Abstract][Full Text] [Related]
40. MUC1-C Stabilizes MCL-1 in the Oxidative Stress Response of Triple-Negative Breast Cancer Cells to BCL-2 Inhibitors.
Hiraki M; Suzuki Y; Alam M; Hinohara K; Hasegawa M; Jin C; Kharbanda S; Kufe D
Sci Rep; 2016 May; 6():26643. PubMed ID: 27217294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
